HKPD · Cellyan Biotechnology Co., Ltd
Market Cap
$16.84M
Shares
48.50M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.35
Open$0.39
Day$0.34–0.40
52W close$0.33–1.74
Avg vol 30d887K
Short int375K · 0.8% float · 7.4d
Short vol48%
DataJan 2025–Aug 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−45%
below
Price vs 50-day avg
−14%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−22%
trailing
6-month return
−45%
trailing
YTD return
−58%
this year
Relative strength
−58%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.77% of float · ▼ -19.8% MoM · 7.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 1-yr range
Squeeze score
49
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
111%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
12.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−45%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+50% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.77% of float · ▼ -19.8% MoM · 7.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 1%
Range high $2
vs 200-day avg -45%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HKPD
this stock
Cellyan Biotechnology Co., Ltd
|
$16.84M | -57.9% | — | — | 0.8% |
|
MCK
Mckesson Corp
|
$104.16B | +8.9% | +3.1% | 24.0 | 2.1% |
|
COR
Cencora, Inc.
|
$61.45B | -4.7% | +9.3% | 23.9 | 2.4% |
|
CAH
Cardinal Health Inc
|
$54.55B | +14.1% | +14.2% | — | 2.7% |
|
HSIC
Henry Schein Inc
|
$9.98B | +18.4% | +5.9% | 26.1 | 6.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
6
- % held
- 0.5%
- Net QoQ
- +182.9K sh
- Top holder
- StoneX Group Inc.
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HKPD | -15.1% | -21.6% | -44.7% | -21.6% | -57.9% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -15.5% | -24.6% | -58.1% | -24.6% | -70.7% |